Zobraziť v EDS

Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study.

Uložené v:
Podrobná bibliografia
Názov: Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study.
Autori: Xing, Xiaoxuan, Wang, Zhizhou, Wang, Ke, Hua, Yiming, Li, Xiaoxi, Le, Kejia, Ma, Wenbing, Guan, Yingyun, Deng, Aiping, Yun, Xiong, Cai, Hongfu, Lyu, Yongning, Xiong, Guoying, Yang, Min, Wang, Siyang, Xue, Chaojun, Zhang, Jing, Guo, Qiushi, Hu, Song, Li, Jing
Zdroj: Lipids in Health & Disease; 10/25/2025, Vol. 24 Issue 1, p1-2, 2p
Predmety: ATORVASTATIN, GENERIC drugs, HYPERGLYCEMIA, PROPENSITY score matching, PHARMACEUTICAL industry, THERAPEUTICS, SAFETY
Geografický termín: CHINA
Abstrakt: The article focuses on a correction made to a previously published study regarding safety outcomes after propensity score (PS) matching in relation to hyperglycemia. The correction clarifies that the proportion of patients experiencing fasting plasma glucose (FPG) increase and new-onset diabetes was lower in the generic group, contrary to the original statement. This amendment aims to ensure the accuracy of the findings presented in the original article. The correction highlights the importance of precise language in medical research to avoid misinterpretation of data. [Extracted from the article]
Copyright of Lipids in Health & Disease is the property of BioMed Central and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Databáza: Complementary Index
Popis
Abstrakt:The article focuses on a correction made to a previously published study regarding safety outcomes after propensity score (PS) matching in relation to hyperglycemia. The correction clarifies that the proportion of patients experiencing fasting plasma glucose (FPG) increase and new-onset diabetes was lower in the generic group, contrary to the original statement. This amendment aims to ensure the accuracy of the findings presented in the original article. The correction highlights the importance of precise language in medical research to avoid misinterpretation of data. [Extracted from the article]
ISSN:1476511X
DOI:10.1186/s12944-025-02777-2